Author

V. A. Co

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

H. El-Nezami· 2 shared M. L. Y. Wan· 2 shared B. Twum· 1 shared D. Zhao· 1 shared M. Sabzichi· 1 shared P. A. Cox· 1 shared P. Dey· 1 shared P.-K. Lee· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

H. El-Nezami

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Schisandrin B suppresses colon cancer growth by inducing cell cycle arrest and apoptosis via the CHOP signalling pathway

V. A. Co, H. El-Nezami, Y. Liu, B. Twum, P. Dey, P. A. Cox, S. Joseph, R. Agbodjan, M. Sabzichi, R. Draheim, M. L. Y. Wan

This study identifies Schisandrin B's mechanism of action in colon cancer, showing it induces cell cycle arrest and apoptosis via the CHOP signalling pathway.

bioRxiv · Aug 27, 2023 · PreprintPharmacology & Toxicology

Bioavailability of Schisandrin B and its effect on 5-Fluorouracil metabolism in a xenograft mouse model of colorectal cancer

P.-K. Lee, V. A. Co, Y. Yang, M. L. Y. Wan, H. El-Nezami, D. Zhao

This study shows Schisandrin B enhances 5-Fluorouracil efficacy in colorectal cancer by modulating drug metabolism and reducing multidrug resistance.

bioRxiv · Nov 28, 2022 · PreprintPharmacology & Toxicology